Diagnostic Testing for Measles
For suspected measles, collect blood for measles IgM antibody testing at the first clinical encounter, and simultaneously collect nasopharyngeal swab or urine for RT-PCR and viral isolation—timing is critical as IgM may be falsely negative if collected within 72 hours of rash onset, requiring repeat testing after 72 hours if initial results are negative. 1
Primary Diagnostic Approach
Serologic Testing (IgM Antibody)
- Collect serum at first clinical encounter with any patient presenting with fever and rash 1
- Use a sensitive and specific assay (direct-capture IgM EIA method preferred) 1
- Critical timing considerations:
Molecular Testing (RT-PCR)
In addition to serology, collect specimens for viral isolation and genetic characterization 1:
Specimen types and optimal timing:
- Nasopharyngeal aspirate/swab: Best specimen type, collect as close to rash onset as possible (ideally ≤3 days) 1, 2
- Urine: Collect within 4-16 days of rash onset 2
- Throat swab: Can detect virus up to 16 days post-rash 2
- Serum for PCR: Highest positive rate (81%) when collected ≤3 days after rash onset 2
Delay in specimen collection reduces viral isolation success 1
Alternative Diagnostic Methods
Acute and Convalescent Serology
- Acute-phase serum: Collect within 1-3 days after rash onset
- Convalescent-phase serum: Collect 2-4 weeks later
- Demonstrates significant rise in antibody titer
- This method has been largely supplanted by single IgM testing 1
Critical Pitfalls and Caveats
False Positive IgM Results
As measles becomes rare, false positive IgM results increase 1:
- Parvovirus infection (fifth disease) can cause false positive measles IgM with certain commercial ELISA assays 1
- Confirmatory testing with direct-capture IgM EIA should be considered when:
- No identified source of infection
- No epidemiologic linkage to confirmed case 1
- Contact state public health laboratory for confirmatory testing 1
Timing-Related False Negatives
- Do not rule out measles based on negative IgM if collected <72 hours after rash onset 1
- Always obtain repeat specimen if initial testing is negative but clinical suspicion persists
Vaccinated Individuals
- Symptomatic reinfections with detectable IgM are rare in previously vaccinated persons 1
- Consider breakthrough infection in vaccinated patients with positive results 3
Laboratory Confirmation Criteria
A confirmed case meets any one of the following 1:
- Positive measles IgM antibody
- Significant rise in measles antibody level between acute and convalescent specimens
- Isolation of measles virus from clinical specimen
Practical Implementation
Immediate Actions
- Do not delay reporting or control measures pending laboratory results 1
- Contact local/state health department immediately for:
- Specimen collection guidance
- Shipping instructions for viral isolation specimens 1
- Outbreak control coordination
Specimen Collection Priority
Collect both serologic AND molecular specimens simultaneously at first encounter to maximize diagnostic yield and enable genotyping for epidemiologic tracking 1, 3
Additional Testing
- Test measles-seronegative patients with febrile rash for rubella 1
Emerging Considerations
Recent research suggests combined diagnostic strategies improve accuracy 4:
- IgM ELISA alone shows detection limitations in samples collected 1-5 days post-rash
- Paired IgG analysis increases diagnostic accuracy (90.7% for RT-PCR vs 67.5% for IgM alone) 4
- PCR demonstrates superior performance in early disease (≤3 days post-rash) 2, 4
The combination of molecular testing with specific IgM and IgG is necessary for correct diagnosis, particularly in elimination settings where distinguishing vaccine failures from wild-type infection is essential 3.